Vishnu Sundaresh is an Endocrinology/Metabolic physician affiliated with University of Utah. OpenAlex indexes 39 publications with 831 citations (h-index 10).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
50 N Medical Dr
Salt Lake City, UT 841320100
Telephone
801-581-7763Provider last certified this registry record 23 Nov 2021.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- GENZYME CORPORATIONProgram year20255 payments
- Blueprint Medicines CorporationProgram year20254 payments
- Blueprint Medicines CorporationProgram year20245 payments$10,719openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Hormonal (systemic)
58.3%l-Thyroxine27.7%Levothyroxine Sodium85%Synthroid15%Part D<11 patientsParathyroid Hormone-Related Peptide Analog11.8%Tymlos100%Part D≥15 patients+ 4 more classes in this area
Metabolism & gastrointestinal
18.1%GLP-1 receptor agonist6.8%Trulicity54%Mounjaro25%Ozempic21%Part D<11 patientsBiguanide (metformin)5.6%Metformin Hcl67%Metformin Hcl Er33%Part D<11 patients+ 2 more classes in this area
Sensory organs
12.2%Corticosteroid12.2%Hydrocortisone70%Solu-Cortef17%Dexamethasone13%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Long-Term Bone Health Outcomes in Patients Treated with Avapritinib for Indolent Systemic Mastocytosis: Findings from the PIONEER study
Journal of Allergy and Clinical Immunology
2026 - Thyroid dysfunction and Research Domain Criteria framework-based depression phenotypes: Insights from a historical longitudinal cohort
Journal of Affective Disorders
2026 - Thyroid Dysfunction and the Risk of Clinically Relevant Depression: A Longitudinal Cohort Study
Mayo Clinic Proceedings
2026
Similar KOLs
Other experts from the same institution or the same specialty.
Howard Colman, MD
University of Utah
Michael Varner, MD
University of Utah
James Fang
University of Utah
Wallace Akerley, MD
University of Utah
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”